Financhill
Back

AbbVie Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
55

ABBV
AbbVie

Last Price:
199.56
Seasonality Move:
5.62%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

AbbVie Price Quote

$199.56
+0.06 (+-0.47%)
(Updated: November 9, 2024 at 5:10 AM ET)

AbbVie Key Stats

Buy
55
AbbVie (ABBV) is a Buy

Day range:
$199.48 - $201.89
52-week range:
$136.30 - $207.32
Dividend yield:
3.11%
P/E ratio:
73.35
P/S ratio:
6.37
P/B ratio:
58.45%

Volume:
4.5M
Avg. volume:
5M
1-year change:
40.46%
Market cap:
$352.5B
Revenue:
$54.3B
EPS:
$2.88

How Much Does AbbVie Make?

  • How Much Are AbbVie's Sales Annually?
    ABBV Revenues are $54.3B
  • How Much Profit Does AbbVie's Make A Year?
    ABBV net income is $4.9B

Is AbbVie Growing As A Company?

  • What Is AbbVie's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.04%
  • What Is AbbVie's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.12%

AbbVie Stock Price Performance

  • Did AbbVie Stock Go Up Last Month?
    AbbVie share price went up by 3.36% last month
  • Did ABBV's Share Price Rise Over The Last Year?
    ABBV share price rose by 40.46% over the past 1 year

What Is AbbVie 52-Week High & Low?

  • What Is AbbVie’s 52-Week High Share Price?
    AbbVie has traded as high as $207.32 over the past 52 weeks
  • What Is AbbVie’s 52-Week Low Share Price?
    AbbVie has traded as low as $136.30 over the past 52 weeks

AbbVie Price To Free Cash Flow

  • Is AbbVie Stock Overvalued?
    AbbVie is trading at a price to free cash flow ratio of 22.64
  • Is AbbVie Stock Undervalued?
    AbbVie EV to Free Cash Flow ratio is 26.65
  • What Is AbbVie’s Price Earnings Growth Ratio?
    ABBV PEG ratio is 0.00
  • Is AbbVie Trading At A Premium To Earnings?
    AbbVie EV to EBIT ratio is 42.20

Is It Risky To Buy AbbVie?

  • How Much Debt Does AbbVie Have?
    Total long term debt quarterly is $71.1B
  • How Much Cash Does AbbVie Have?
    Cash and short term investments quarterly total is $7.3B
  • What Is AbbVie’s Book Value Per Share?
    Book value per share is 3.41

Is AbbVie Cash Flow Positive?

  • What Is ABBV Cash Flow From Operations?
    Cash flow from operations (TTM) is $16.5B
  • What Is AbbVie’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$2.8B
  • What Is AbbVie’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$19.7B

AbbVie Return On Invested Capital

  • Is Management Doing A Good Job?
    ABBV return on invested capital is 6.75%
  • What Is AbbVie Return On Assets?
    ROA measures how assets are converting to revenues and is 3.63%
  • What Is ABBV Return On Equity?
    ROE is a measure of profitability and is 58.92%

AbbVie Earnings Date & Stock Price

  • What Is AbbVie's Stock Price Today?
    A single share of ABBV can be purchased today for 199.50
  • What Is AbbVie’s Stock Symbol?
    AbbVie trades on the S&P500 under the ticker symbol: ABBV
  • When Is AbbVie’s Next Earnings Date?
    The next quarterly earnings date for AbbVie is scheduled on January 31, 2025
  • When Is ABBV's next ex-dividend date?
    AbbVie's next ex-dividend date is January 15, 2025
  • How To Buy AbbVie Stock?
    You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

AbbVie Competitors

  • Who Are AbbVie's Competitors?
    Below is a list of companies who compete with AbbVie or are related in some way:
    • Amgen Inc (AMGN)
    • Johnson & Johnson (JNJ)
    • Eli Lilly and Co (LLY)
    • Merck & Co Inc (MRK)
    • Pfizer Inc (PFE)

AbbVie Dividend Yield

  • What Is ABBV Dividend Yield?
    AbbVie’s dividend yield currently is 3.11%
  • What Is AbbVie’s Payout Ratio?
    AbbVie’s payout ratio is 212.79%
  • When Did AbbVie Last Pay A Dividend?
    The latest dividend pay date is November 10, 2024
  • What Is AbbVie’s Dividend Per Share?
    AbbVie pays a dividend of $1.55 per share

AbbVie Analyst Estimates

YoY Growth Past Surprise
EPS: -12% 2.82%
Revenue: 3.83% 1.28%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 9
Sell Recommendations: 0
Price Target: 209.55
Upside from Last Price: 5.04%

Major Shareholders

  • How many ABBV shares are owned by institutional investors?
    2.2B ABBV shares are owned by institutional investors
  • How many ABBV shares are owned by insiders?
    2.4M ABBV shares are owned by insiders